Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease

被引:0
|
作者
Sarah M. Rothman
Mark P. Mattson
机构
[1] Laboratory of Neurosciences,
[2] National Institute on Aging Intramural Research Program,undefined
来源
NeuroMolecular Medicine | 2010年 / 12卷
关键词
Alzheimer’s disease; Chronic stress; Glucocorticoids; Hippocampal plasticity;
D O I
暂无
中图分类号
学科分类号
摘要
Recent clinical data have implicated chronic adverse stress as a potential risk factor in the development of Alzheimer’s disease (AD) and data also suggest that normal, physiological stress responses may be impaired in AD. It is possible that pathology associated with AD causes aberrant responses to chronic stress, due to potential alterations in the hypothalamic–pituitary–adrenal (HPA) axis. Recent study in rodent models of AD suggests that chronic adverse stress exacerbates the cognitive deficits and hippocampal pathology that are present in the AD brain. This review summarizes recent findings obtained in experimental AD models regarding the influence of chronic adverse stress on the underlying cellular and molecular disease processes including the potential role of glucocorticoids. Emerging findings suggest that both AD and chronic adverse stress affect hippocampal neural networks in a similar fashion. We describe alterations in hippocampal plasticity, which occur in both chronic stress and AD including dendritic remodeling, neurogenesis, and long-term potentiation. Finally, we outline potential roles for oxidative stress and neurotrophic factor signaling as the key determinants of the impact of chronic stress on the plasticity of neural networks and AD pathogenesis.
引用
收藏
页码:56 / 70
页数:14
相关论文
共 50 条
  • [31] Is hypertension a predictor of hippocampal atrophy in Alzheimer's disease?
    Dhikav, Vikas
    Verma, Myank
    Anand, Kuljeet
    INTERNATIONAL PSYCHOGERIATRICS, 2009, 21 (04) : 795 - 796
  • [32] Sleep and hippocampal neurogenesis: Implications for Alzheimer's disease
    Kent, Brianne A.
    Mistlberger, Ralph E.
    FRONTIERS IN NEUROENDOCRINOLOGY, 2017, 45 : 35 - 52
  • [33] HIPPOCAMPAL PLASTICITY DURING THE PROGRESSION OF ALZHEIMER'S DISEASE
    Mufson, E. J.
    Mahady, L.
    Waters, D.
    Counts, S. E.
    Perez, S. E.
    Dekosky, S. T.
    Ginsberg, S. D.
    Ikonomovic, M. D.
    Scheff, S. W.
    Binder, L. I.
    NEUROSCIENCE, 2015, 309 : 51 - 67
  • [34] The imitation game: Alzheimer's Disease or Hippocampal Sclerosis
    Sharma, K. D.
    Niknejad, B.
    Okhravi, H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S196 - S197
  • [35] Potential Predictors of Hippocampal Atrophy in Alzheimer's Disease
    Dhikav, Vikas
    Anand, Kuljeet
    DRUGS & AGING, 2011, 28 (01) : 1 - 11
  • [36] Hippocampal Hyperactivation in Presymptomatic Familial Alzheimer's Disease
    Quiroz, Yakeel T.
    Budson, Andrew E.
    Celone, Kim
    Ruiz, Adriana
    Newmark, Rardall
    Castrillon, Gabriel
    Lopera, Francisco
    Stern, Chantal E.
    ANNALS OF NEUROLOGY, 2010, 68 (06) : 865 - 875
  • [37] Proteomics analysis of the Alzheimer's disease hippocampal proteome
    Sultana, Rukhsana
    Boyd-Kimball, Debra
    Cai, Jain
    Pierce, William M.
    Klein, Jon B.
    Merchant, Michael
    Butterfield, D. Allan
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (02) : 153 - 164
  • [38] Multivariate Prediction of Hippocampal Atrophy in Alzheimer's Disease
    Liedes, Hilkka
    Lotjonen, Jyrki
    Kortelainen, Juha M.
    Novak, Gerald
    van Gils, Mark
    Gordon, Mark Forrest
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (04) : 1453 - 1468
  • [39] Hippocampal neuronal density in Alzheimer's disease.
    Kim, JH
    Je, S
    Huh, G
    Ciesielski, TE
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (05): : 552 - 552
  • [40] Potential Predictors of Hippocampal Atrophy in Alzheimer’s Disease
    Vikas Dhikav
    Kuljeet Anand
    Drugs & Aging, 2011, 28 : 1 - 11